These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25101540)

  • 21. Stimulation of cortical acetylcholine release by orexin A.
    Fadel J; Pasumarthi R; Reznikov LR
    Neuroscience; 2005; 130(2):541-7. PubMed ID: 15664710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases.
    Koshy Cherian A; Kucinski A; Pitchers K; Yegla B; Parikh V; Kim Y; Valuskova P; Gurnani S; Lindsley CW; Blakely RD; Sarter M
    J Neurosci; 2017 Mar; 37(11):2947-2959. PubMed ID: 28193693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis.
    Orciani C; Hall H; Pentz R; Foret MK; Do Carmo S; Cuello AC
    J Neurochem; 2022 Oct; 163(2):149-167. PubMed ID: 35921478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aβ selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: implication in Alzheimer's disease.
    Gu Z; Cheng J; Zhong P; Qin L; Liu W; Yan Z
    J Neurosci; 2014 Oct; 34(41):13614-28. PubMed ID: 25297090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats.
    Kozak R; Martinez V; Young D; Brown H; Bruno JP; Sarter M
    Neuropsychopharmacology; 2007 Oct; 32(10):2074-86. PubMed ID: 17299502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-amyloid peptides inhibit acetylcholine release from cholinergic presynaptic nerve endings isolated from an electric ray.
    Satoh Y; Hirakura Y; Shibayama S; Hirashima N; Suzuki T; Kirino Y
    Neurosci Lett; 2001 Apr; 302(2-3):97-100. PubMed ID: 11290396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats.
    Rylett RJ; Goddard S; Schmidt BM; Williams LR
    J Neurosci; 1993 Sep; 13(9):3956-63. PubMed ID: 8366354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory.
    Gulisano W; Melone M; Ripoli C; Tropea MR; Li Puma DD; Giunta S; Cocco S; Marcotulli D; Origlia N; Palmeri A; Arancio O; Conti F; Grassi C; Puzzo D
    J Neurosci; 2019 Jul; 39(30):5986-6000. PubMed ID: 31127002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Aβ) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons.
    Ovsepian SV; Antyborzec I; O'Leary VB; Zaborszky L; Herms J; Oliver Dolly J
    Brain Struct Funct; 2014 Sep; 219(5):1527-41. PubMed ID: 23716278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens.
    Preda S; Govoni S; Lanni C; Racchi M; Mura E; Grilli M; Marchi M
    Neuropsychopharmacology; 2008 Apr; 33(5):1062-70. PubMed ID: 17581530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.
    Kar S; Slowikowski SP; Westaway D; Mount HT
    J Psychiatry Neurosci; 2004 Nov; 29(6):427-41. PubMed ID: 15644984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
    Zhang W; Bai M; Xi Y; Hao J; Liu L; Mao N; Su C; Miao J; Li Z
    Free Radic Biol Med; 2012 Apr; 52(8):1443-52. PubMed ID: 22342520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disrupted Choline Clearance and Sustained Acetylcholine Release
    Donovan E; Avila C; Klausner S; Parikh V; Fenollar-Ferrer C; Blakely RD; Sarter M
    J Neurosci; 2022 Apr; 42(16):3426-3444. PubMed ID: 35232764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats.
    Tomassoni D; Catalani A; Cinque C; Di Tullio MA; Tayebati SK; Cadoni A; Nwankwo IE; Traini E; Amenta F
    Curr Alzheimer Res; 2012 Jan; 9(1):120-7. PubMed ID: 22191561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells.
    Heinitz K; Beck M; Schliebs R; Perez-Polo JR
    J Neurochem; 2006 Sep; 98(6):1930-45. PubMed ID: 16945109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers.
    Nunes-Tavares N; Santos LE; Stutz B; Brito-Moreira J; Klein WL; Ferreira ST; de Mello FG
    J Biol Chem; 2012 Jun; 287(23):19377-85. PubMed ID: 22505713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.